Literature DB >> 16055712

The mSin3A chromatin-modifying complex is essential for embryogenesis and T-cell development.

Shaun M Cowley1, Brian M Iritani, Susan M Mendrysa, Tina Xu, Pei Feng Cheng, Jason Yada, H Denny Liggitt, Robert N Eisenman.   

Abstract

The corepressor mSin3A is the core component of a chromatin-modifying complex that is recruited by multiple gene-specific transcriptional repressors. In order to understand the role of mSin3A during development, we generated constitutive germ line as well as conditional msin3A deletions. msin3A deletion in the developing mouse embryo results in lethality at the postimplantation stage, demonstrating that it is an essential gene. Blastocysts derived from preimplantation msin3A null embryos and mouse embryo fibroblasts (MEFs) lacking msin3A display a significant reduction in cell division. msin3A null MEFs also show mislocalization of the heterochromatin protein, HP1alpha, without alterations in global histone acetylation. Heterozygous msin3A(+/-) mice with a systemic twofold decrease in mSin3A protein develop splenomegaly as well as kidney disease indicative of a disruption of lymphocyte homeostasis. Conditional deletion of msin3A from developing T cells results in reduced thymic cellularity and a fivefold decrease in the number of cytotoxic (CD8) T cells, while helper (CD4) T cells are unaffected. We show that CD8 development is dependent on mSin3A at a step downstream of T-cell receptor signaling and that loss of mSin3A specifically decreases survival of double-positive and CD8 T cells. Thus, msin3A is a pleiotropic gene which, in addition to its role in cell cycle progression, is required for the development and homeostasis of cells in the lymphoid lineage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055712      PMCID: PMC1190252          DOI: 10.1128/MCB.25.16.6990-7004.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  77 in total

1.  Lck activity controls CD4/CD8 T cell lineage commitment.

Authors:  G Hernández-Hoyos; S J Sohn; E V Rothenberg; J Alberola-Ila
Journal:  Immunity       Date:  2000-03       Impact factor: 31.745

2.  Epiblast-restricted Cre expression in MORE mice: a tool to distinguish embryonic vs. extra-embryonic gene function.

Authors:  M D Tallquist; P Soriano
Journal:  Genesis       Date:  2000-02       Impact factor: 2.487

3.  The Mad1-Sin3B interaction involves a novel helical fold.

Authors:  C A Spronk; M Tessari; A M Kaan; J F Jansen; M Vermeulen; H G Stunnenberg; G W Vuister
Journal:  Nat Struct Biol       Date:  2000-12

4.  The corepressor mSin3a interacts with the proline-rich domain of p53 and protects p53 from proteasome-mediated degradation.

Authors:  J T Zilfou; W H Hoffman; M Sank; D L George; M Murphy
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

5.  Sds3 (suppressor of defective silencing 3) is an integral component of the yeast Sin3[middle dot]Rpd3 histone deacetylase complex and is required for histone deacetylase activity.

Authors:  T Lechner; M J Carrozza; Y Yu; P A Grant; A Eberharter; D Vannier; G Brosch; D J Stillman; D Shore; J L Workman
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

6.  Roles for the Saccharomyces cerevisiae SDS3, CBK1 and HYM1 genes in transcriptional repression by SIN3.

Authors:  S Dorland; M L Deegenaars; D J Stillman
Journal:  Genetics       Date:  2000-02       Impact factor: 4.562

7.  Purification and characterization of mSin3A-containing Brg1 and hBrm chromatin remodeling complexes.

Authors:  S Sif; A J Saurin; A N Imbalzano; R E Kingston
Journal:  Genes Dev       Date:  2001-03-01       Impact factor: 11.361

8.  Solution structure of the interacting domains of the Mad-Sin3 complex: implications for recruitment of a chromatin-modifying complex.

Authors:  K Brubaker; S M Cowley; K Huang; L Loo; G S Yochum; D E Ayer; R N Eisenman; I Radhakrishnan
Journal:  Cell       Date:  2000-11-10       Impact factor: 41.582

9.  Reversible disruption of pericentric heterochromatin and centromere function by inhibiting deacetylases.

Authors:  A Taddei; C Maison; D Roche; G Almouzni
Journal:  Nat Cell Biol       Date:  2001-02       Impact factor: 28.824

10.  RBP1 recruits the mSIN3-histone deacetylase complex to the pocket of retinoblastoma tumor suppressor family proteins found in limited discrete regions of the nucleus at growth arrest.

Authors:  A Lai; B K Kennedy; D A Barbie; N R Bertos; X J Yang; M C Theberge; S C Tsai; E Seto; Y Zhang; A Kuzmichev; W S Lane; D Reinberg; E Harlow; P E Branton
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

View more
  70 in total

1.  Haploinsufficiency of MeCP2-interacting transcriptional co-repressor SIN3A causes mild intellectual disability by affecting the development of cortical integrity.

Authors:  Josefine S Witteveen; Marjolein H Willemsen; Thaís C D Dombroski; Nick H M van Bakel; Willy M Nillesen; Josephus A van Hulten; Eric J R Jansen; Dave Verkaik; Hermine E Veenstra-Knol; Conny M A van Ravenswaaij-Arts; Jolien S Klein Wassink-Ruiter; Marie Vincent; Albert David; Cedric Le Caignec; Jolanda Schieving; Christian Gilissen; Nicola Foulds; Patrick Rump; Tim Strom; Kirsten Cremer; Alexander M Zink; Hartmut Engels; Sonja A de Munnik; Jasper E Visser; Han G Brunner; Gerard J M Martens; Rolph Pfundt; Tjitske Kleefstra; Sharon M Kolk
Journal:  Nat Genet       Date:  2016-07-11       Impact factor: 38.330

2.  mSin3A corepressor regulates diverse transcriptional networks governing normal and neoplastic growth and survival.

Authors:  Jan-Hermen Dannenberg; Gregory David; Sheng Zhong; Jaco van der Torre; Wing H Wong; Ronald A Depinho
Journal:  Genes Dev       Date:  2005-07-01       Impact factor: 11.361

3.  Conserved themes in target recognition by the PAH1 and PAH2 domains of the Sin3 transcriptional corepressor.

Authors:  Sarata C Sahu; Kurt A Swanson; Richard S Kang; Kai Huang; Kurt Brubaker; Kathleen Ratcliff; Ishwar Radhakrishnan
Journal:  J Mol Biol       Date:  2007-12-04       Impact factor: 5.469

4.  Specific requirement of the chromatin modifier mSin3B in cell cycle exit and cellular differentiation.

Authors:  Gregory David; Kathryn B Grandinetti; Patricia M Finnerty; Natalie Simpson; Gerald C Chu; Ronald A Depinho
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-10       Impact factor: 11.205

Review 5.  The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men.

Authors:  Xiang-Jiao Yang; Edward Seto
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

6.  A positive regulatory role for the mSin3A-HDAC complex in pluripotency through Nanog and Sox2.

Authors:  Gretchen A Baltus; Michael P Kowalski; Antonin V Tutter; Shilpa Kadam
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

7.  The SIN3A/HDAC Corepressor Complex Functionally Cooperates with NANOG to Promote Pluripotency.

Authors:  Arven Saunders; Xin Huang; Miguel Fidalgo; Michael H Reimer; Francesco Faiola; Junjun Ding; Carlos Sánchez-Priego; Diana Guallar; Carmen Sáenz; Dan Li; Jianlong Wang
Journal:  Cell Rep       Date:  2017-02-14       Impact factor: 9.423

8.  Sin3a-associated Hdac1 and Hdac2 are essential for hematopoietic stem cell homeostasis and contribute differentially to hematopoiesis.

Authors:  Marinus R Heideman; Cesare Lancini; Natalie Proost; Eva Yanover; Heinz Jacobs; Jan-Hermen Dannenberg
Journal:  Haematologica       Date:  2014-04-24       Impact factor: 9.941

Review 9.  The potential of targeting Sin3B and its associated complexes for cancer therapy.

Authors:  David J Cantor; Gregory David
Journal:  Expert Opin Ther Targets       Date:  2017-10-09       Impact factor: 6.902

10.  Coregulator Sin3a Promotes Postnatal Murine β-Cell Fitness by Regulating Genes in Ca2+ Homeostasis, Cell Survival, Vesicle Biosynthesis, Glucose Metabolism, and Stress Response.

Authors:  Xiaodun Yang; Sarah M Graff; Cody N Heiser; Kung-Hsien Ho; Bob Chen; Alan J Simmons; Austin N Southard-Smith; Gregory David; David A Jacobson; Irina Kaverina; Christopher V E Wright; Ken S Lau; Guoqiang Gu
Journal:  Diabetes       Date:  2020-04-03       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.